Prognostic value of xenograft engraftment in patients with metastatic high-risk neuroblastoma.
Rosario AscheroHelena Castillo-EcijaMerce Baulenas-FarresClaudia Resa-ParesAna Jimenez-CabacoEva RodriguezCarles MonterrubioSara Perez-JaumeMariona SuñolGuillermo L ChantadaCinzia LavarinoJaume MoraAngel Montero CarcabosoPublished in: Pediatric blood & cancer (2023)
Positive PDX engraftment is a factor related to poor prognosis and fatal outcome in patients with stage M HR-NB treated with up-to-date therapies.